These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34876018)

  • 21. A novel study to examine the association of
    Reddy S; Kaur N; Singh J
    J Genet; 2018 Dec; 97(5):1371-1378. PubMed ID: 30555085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Dongiovanni P; Meroni M; Baselli G; Mancina RM; Ruscica M; Longo M; Rametta R; Cespiati A; Pelusi S; Ferri N; Ranzani V; Nobili V; Pihlajamaki J; Fracanzani AL; Badiali S; Petta S; Fargion S; Romeo S; Kozlitina J; Valenti L
    J Lipid Res; 2019 Jun; 60(6):1144-1153. PubMed ID: 30918065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.
    Hasan EM; Abd Al Aziz RA; Sabry D; Darweesh SK; Badary HA; Elsharkawy A; Abouelkhair MM; Yosry A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):265-272. PubMed ID: 30240470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis.
    Paquette M; Gauthier D; Chamberland A; Prat A; De Lucia Rolfe E; Rasmussen JJ; Kaduka L; Seidah NG; Bernard S; Christensen DL; Baass A
    Clin Biochem; 2020 Mar; 77():20-25. PubMed ID: 31972148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.
    Furuhashi M; Kataoka Y; Nishikawa R; Koyama M; Sakai A; Higashiura Y; Tanaka M; Saitoh S; Shimamoto K; Ohnishi H
    J Atheroscler Thromb; 2022 Sep; 29(9):1275-1284. PubMed ID: 34565765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
    Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
    Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
    Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
    Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.
    Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P
    Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease.
    Balcar L; Scheiner B; Urheu M; Weinberger P; Paternostro R; Simbrunner B; Semmler G; Willheim C; Pinter M; Ferenci P; Trauner M; Reiberger T; Stättermayer AF; Mandorfer M
    Dig Liver Dis; 2023 Aug; 55(8):1072-1080. PubMed ID: 36863929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E
    Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.
    Qiu C; Zeng P; Li X; Zhang Z; Pan B; Peng ZYF; Li Y; Ma Y; Leng Y; Chen R
    Lipids Health Dis; 2017 Jun; 16(1):111. PubMed ID: 28606094
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock.
    Atreya MR; Whitacre BE; Cvijanovich NZ; Bigham MT; Thomas NJ; Schwarz AJ; Weiss SL; Fitzgerald JC; Allen GL; Lutfi R; Nowak JE; Quasney MW; Shah AS; Wong HR
    Crit Care Med; 2020 Oct; 48(10):1513-1520. PubMed ID: 32769621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis.
    Emma MR; Giannitrapani L; Cabibi D; Porcasi R; Pantuso G; Augello G; Giglio RV; Re NL; Capitano AR; Montalto G; Soresi M; Cervello M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158792. PubMed ID: 32777481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.
    Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S
    Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Meroni M; Longo M; Lombardi R; Paolini E; Macchi C; Corsini A; Sirtori CR; Fracanzani AL; Ruscica M; Dongiovanni P
    Hepatol Commun; 2022 Mar; 6(3):535-549. PubMed ID: 34677008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis.
    Li XY; Liu Z; Li L; Wang HJ; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1026901. PubMed ID: 36353245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of
    Wang J; Li S; Ren Y; Wang G; Li W
    J Integr Neurosci; 2024 Mar; 23(3):62. PubMed ID: 38538222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing
    Lebeau PF; Byun JH; Platko K; MacDonald ME; Poon SV; Faiyaz M; Seidah NG; Austin RC
    J Biol Chem; 2019 Jun; 294(23):9037-9047. PubMed ID: 31004037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.